For decades, a diagnosis of Sickle Cell Disorder (SCD) in Nigeria was met with a heavy sense of permanence. As the country ...

A top congressional Republican on Sunday criticized President Barack Obama's expected decision to reverse the Bush administration's limits on embryonic stem-cell research, calling it a distraction ...

Regenerative Medicine Clinic Returns to Southwest Florida with comprehensive PRP therapy and Stem Cell Treatments FORT ...

A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...

Shares of Japan's Sumitomo Pharma fell over 15% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinson's disease.

A new brain implant trial aims to restore lost dopamine cells in Parkinson’s patients. Researchers are now testing it in ...

BioRestorative (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. As described below, our two core clinical development ...

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

The gross proceeds to the Company from the offering are expected to be approximately $5.0 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The ...

Following Mesoblast's breakthrough FDA approval for its stem-cell therapy, activity in the sector has burgeoned. Investors – stay tuned!

Breakthrough research from the University of Cincinnati College of Medicine is revealing how immune cells in the adult brain can regulate the generation of new neurons.